SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Reserve excluding Revaluation Reserve History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Reserve excluding Revaluation Reserve | ₹248 Cr | ₹194 Cr | ₹162 Cr | ₹131 Cr | ₹39 Cr |
What is the latest Reserve excluding Revaluation Reserve ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Reserve excluding Revaluation Reserve |
|---|---|
| Mar2025 | ₹248 Cr |
| Mar2024 | ₹194 Cr |
| Mar2023 | ₹162 Cr |
| Mar2022 | ₹131 Cr |
| Mar2017 | ₹39 Cr |
How is Reserve excluding Revaluation Reserve of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Reserve excluding Revaluation Reserve | % Change | |
|---|---|---|---|
| Mar2025 | ₹248 Cr | 27.82 | |
| Mar2024 | ₹194 Cr | 19.83 | |
| Mar2023 | ₹162 Cr | 23.74 | |
| Mar2022 | ₹131 Cr | 233.26 | |
| Mar2017 | ₹39 Cr | - | |
Compare Reserve excluding Revaluation Reserve of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,440.1 Cr | -1.7% | -7.7% | -23.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,343.0 Cr | -0.2% | 5.8% | 0.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,774.0 Cr | -0.6% | -5.2% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,665.0 Cr | -0.5% | 2.5% | 12.1% | Stock Analytics | |
| CIPLA | ₹122,878.0 Cr | -1.1% | -0.2% | -1.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,581.0 Cr | 2.4% | 7% | 6.2% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -1.7% |
-7.7% |
-23.1% |
| SENSEX | -0.5% |
1.5% |
6.9% |
You may also like the below Video Courses